Test Price
2,800 AED✅ Home Collection Available
ITPR1 Gene Spinocerebellar Ataxia Type 15 Genetic Test in UAE | 2,800 AED
Executive Summary & Core Metrics
- Diagnostic Accuracy: 99.9% analytical sensitivity via ISO 9001:2015 certified process in a DHA-licensed laboratory.
- VIP Home Phlebotomy: Temperature-controlled cold-chain collection available daily 8 AM – 11 PM across Dubai and the UAE.
- Post-Test Genetic Counseling: Telephone session with a board-certified geneticist included in the service.
- Insurance Verification: Direct real-time check via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
This Next‑Generation Sequencing (NGS) test analyzes the ITPR1 gene to confirm a diagnosis of Spinocerebellar Ataxia Type 15 (SCA15), a slowly progressive autosomal dominant ataxia. Our laboratory provides comprehensive coverage of all coding exons and flanking intronic regions, ensuring detection of single nucleotide variants, small insertions/deletions, and splice-site alterations.
| Feature | Our Test | Closest Alternative |
|---|---|---|
| Methodology | NGS (full coding + flanking intronic regions) | Sanger sequencing (selected exons only) |
| Target Coverage | ≥200× mean depth, >99% bases covered at ≥20× | Varies, often lower for GC‑rich regions |
| Turnaround Time | 21 calendar days (3–4 weeks max) | 4–6 weeks |
| Bioinformatics | ClinGen‑curated variant classification (ACMG/AMP) | Limited in silico tools |
| Reporting | DHA‑compliant PDF with LOINC‑linked identifiers | Generic lab report |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh (Consultant Medical Genetics, DHA ID: 9294403) states: “Every ITPR1 genetic report must be interpreted in the full context of the patient’s clinical history and family pedigree. A negative result does not exclude other hereditary ataxias, and a positive finding provides diagnostic clarity but requires tailored follow-up. Patients should always discuss results with a neurologist or genetic counselor experienced in movement disorders.”
Medication & Clinical Advisory
Do not discontinue any prescribed medications (including anti‑epileptics, muscle relaxants, or supplements) without consulting your treating physician. Genetic testing is a diagnostic tool, not a substitute for ongoing neurological care.
Exclusion Criteria & Emergency Red Flags
- This test is not indicated for asymptomatic minors without a confirmed familial mutation – consent must follow Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Inability to provide informed consent (legal guardian required).
- If you experience sudden worsening of gait, speech difficulties, or swallowing problems, proceed immediately to the nearest emergency room; delay may mask reversible causes.
Patient FAQ & Clinical Guidance
1. What is the difference between this test and a brain MRI for ataxia?
The ITPR1 gene NGS test definitively identifies the underlying genetic mutation causing SCA15, whereas MRI only visualizes cerebellar atrophy that may appear years after clinical onset. Genetic testing provides a molecular diagnosis, enabling precise family counseling and risk assessment.
2. What sample type is required, and can it be collected at home?
We accept whole blood (2–3 mL in EDTA), extracted DNA, or a single dried blood spot on an FTA card. Our VIP mobile phlebotomy team performs home collection under strict cold-chain protocol daily from 8 AM to 11 PM across the UAE.
3. Will my health insurance cover the cost of this genetic test?
We provide direct insurance verification via WhatsApp (+971 54 548 8731). Many UAE insurers cover neurological genetic testing when pre‑authorized by a DHA‑licensed neurologist and coded under ICD‑10 G11.8. Contact us for a complimentary eligibility check.
UAE Regulatory & Data Privacy Adherence
All genetic data is processed in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Results are encrypted, access‑controlled, and never shared without explicit patient consent. The laboratory holds DHA license number 1143 and operates under the regulatory oversight of the Dubai Health Authority.
Clinical & Logistical Metadata
| Test Name | ITPR1 Gene Spinocerebellar Ataxia Type 15 Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 21 calendar days |
| Sample Type / Matrix | Whole blood (EDTA), extracted DNA, or dried blood spot (FTA card) |
| Methodology Used | Next-Generation Sequencing (NGS) – full coding and flanking intronic regions |
| ICD-10-CM Code | G11.8 |
| LOINC Code | 94077-1 |
| DHA Facility License & Laboratory Address | License 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE (DNA Labs UAE) |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians